1st Detect Awarded a Homeland Security Research and Development Contract to Expand the TRACER 1000™ Explosive Threat Detection
Astrotech (NASDAQ: ASTC) and its subsidiary 1st Detect have secured a research and development contract from the U.S. Department of Homeland Security (DHS) to enhance their TRACER 1000 explosives trace detection system. The contract, numbered 70RSAT24CB0000015, aims to develop improved detection capabilities against evolving security threats.
The project is structured in two 15-month phases with a total potential value of $1,290,650. Phase 1 is valued at $581,639, while Phase 2, which is optional and dependent on successful completion of Phase 1, is worth $709,011. The entire project spans 30 months and aligns with DHS's Long Range Broad Agency Announcement No. 18-01 objectives.
Astrotech (NASDAQ: ASTC) e la sua sussidiaria 1st Detect hanno ottenuto un contratto di ricerca e sviluppo dal Dipartimento della Sicurezza Nazionale degli Stati Uniti (DHS) per migliorare il loro sistema di rilevamento delle tracce esplosive TRACER 1000. Il contratto, numero 70RSAT24CB0000015, ha l'obiettivo di sviluppare capacità di rilevamento migliorate contro le minacce alla sicurezza in evoluzione.
Il progetto è strutturato in due fasi di 15 mesi ciascuna, con un valore potenziale totale di 1.290.650 $. La Fase 1 ha un valore di 581.639 $, mentre la Fase 2, che è opzionale e dipende dal completamento riuscito della Fase 1, vale 709.011 $. L'intero progetto si estende per 30 mesi e si allinea con gli obiettivi dell'Avviso di Agenzia Largo a Lungo Termine No. 18-01 del DHS.
Astrotech (NASDAQ: ASTC) y su filial 1st Detect han asegurado un contrato de investigación y desarrollo del Departamento de Seguridad Nacional de EE. UU. (DHS) para mejorar su sistema de detección de trazas explosivas TRACER 1000. El contrato, número 70RSAT24CB0000015, tiene como objetivo desarrollar capacidades de detección mejoradas contra amenazas a la seguridad en evolución.
El proyecto está estructurado en dos fases de 15 meses, con un valor total potencial de $1,290,650. La Fase 1 está valorada en $581,639, mientras que la Fase 2, que es opcional y depende de la finalización exitosa de la Fase 1, tiene un valor de $709,011. Todo el proyecto abarca 30 meses y se alinea con los objetivos del Anuncio Amplio de Agencia de Largo Alcance No. 18-01 del DHS.
Astrotech (NASDAQ: ASTC)와 그 자회사 1st Detect는 미국 국토안보부(DHS)로부터 TRACER 1000 폭발물 흔적 탐지 시스템을 개선하기 위한 연구 개발 계약을 체결했습니다. 계약 번호 70RSAT24CB0000015는 진화하는 보안 위협에 대한 향상된 탐지 능력을 개발하는 것을 목표로 하고 있습니다.
이 프로젝트는 2개의 15개월 단계로 구성되며, 총 잠재 가치가 1,290,650 달러입니다. 1단계는 581,639 달러의 가치가 있으며, 1단계가 성공적으로 완료될 경우 선택적이고 가치는 709,011 달러인 2단계가 있습니다. 전체 프로젝트는 30개월에 걸쳐 진행되며 DHS의 연장된 광범위한 기관 공고 제 18-01과 일치합니다.
Astrotech (NASDAQ: ASTC) et sa filiale 1st Detect ont obtenu un contrat de recherche et développement du Département de la Sécurité intérieure des États-Unis (DHS) pour améliorer leur système de détection de traces d'explosifs TRACER 1000. Le contrat, numéroté 70RSAT24CB0000015, vise à développer des capacités de détection améliorées contre les menaces à la sécurité en évolution.
Le projet est structuré en deux phases de 15 mois, avec une valeur potentielle totale de 1.290.650 $. La phase 1 est évaluée à 581.639 $, tandis que la phase 2, qui est optionnelle et dépend de l'achèvement réussi de la phase 1, vaut 709.011 $. L'ensemble du projet s'étend sur 30 mois et s'aligne sur les objectifs de l'Annonce large de l'Agence de long terme n° 18-01 du DHS.
Astrotech (NASDAQ: ASTC) und ihre Tochtergesellschaft 1st Detect haben einen Forschungs- und Entwicklungsvertrag vom US-Ministerium für Heimatschutz (DHS) erhalten, um ihr explosives Rückstandserkennungssystem TRACER 1000 zu verbessern. Der Vertrag mit der Nummer 70RSAT24CB0000015 zielt darauf ab, verbesserte Erkennungsfähigkeiten gegen sich entwickelte Bedrohungen für die Sicherheit zu entwickeln.
Das Projekt ist in zwei Phasen von jeweils 15 Monaten gegliedert und hat einen gesamtpotenziellen Wert von 1.290.650 $. Phase 1 hat einen Wert von 581.639 $, während Phase 2, die optional ist und von einem erfolgreichen Abschluss der Phase 1 abhängt, 709.011 $ wert ist. Das gesamte Projekt erstreckt sich über 30 Monate und entspricht den Zielen der Bekanntmachung 18-01 des DHS.
- Secured new R&D contract worth $1.29M with DHS
- Contract validates TRACER 1000's capabilities after DHS evaluation
- Potential for additional $709,011 in Phase 2 funding
- Phase 2 funding contingent on Phase 1 performance
- Extended 30-month timeline before full contract value realization
Insights
The
For a company of ASTC's size, this contract could materially impact revenues and validate their technology in the homeland security sector. The R&D focus on next-generation explosive detection capabilities aligns with increasing government emphasis on advanced security technologies, potentially opening doors to larger operational contracts if successful.
The TRACER 1000's selection for DHS next-generation ETD research signals strong technical merit in an increasingly critical security domain. The focus on combating evolving threat evasion tactics positions this technology at the forefront of aviation security innovation. For context, explosive trace detection represents a important layer in multi-tiered airport security, where even incremental improvements can have significant operational impact.
In simpler terms - this is like getting picked to develop the next generation of security screening technology that keeps airports safe. The government essentially saying "we believe your technology has potential to be the future standard" is a major vote of confidence for a small company like Astrotech.
AUSTIN, Texas, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ: ASTC) ("Astrotech" or the "Company") and its wholly-owned subsidiary, 1st Detect Corporation, announced that the Company has been awarded research and development (“R&D”) contract 70RSAT24CB0000015 (“Contract”) with the U.S. Department of Homeland Security (“DHS”) to research, develop and mature the TRACER 1000 for DHS next generation explosives trace detection (“ETD”).
The Contract is in support of the objectives stated in the DHS Long Range Broad Agency Announcement No. 18-01 (the “Announcement”). According to the Announcement, the purpose of this technical research is to develop new and improved ETD capabilities to address the increasing number of threats and tactics used to evade detection.
The research project is broken into two phases that each span 15 months. The contract has a total potential value of
Tom Pickens, CEO and CTO of Astrotech, said: “The Tracer 1000TM has been thoroughly evaluated by DHS and based on its capability, the Company has been awarded this important R&D project. We are pleased to receive this award and look forward to working with DHS in the development of the next generation explosive detectors. This new generation of ETDs will aid the effort of continuing to secure the safety of the world’s passengers, airports and airways.”
About Astrotech Corporation
Astrotech (Nasdaq: ASTC) is a mass spectrometry company that launches, manages and commercializes scalable companies based on its innovative core technology through its wholly owned subsidiaries. 1st Detect develops, manufactures, and sells trace detectors for use in the security and detection market. Astrotech is headquartered in Austin, Texas. For information, please visit www.astrotechcorp.com.
Forward-Looking Statements
This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, the adverse impact of inflationary pressures, including significant increases in fuel costs, global economic conditions and events related to these conditions, including the ongoing wars in Ukraine and the Middle East and the COVID-19 pandemic, the Company’s use of proceeds from the common stock offerings, whether we can successfully complete the development of our new products and proprietary technologies, whether we can obtain the FDA and other regulatory approvals required to market our products under development in the United States or abroad, whether the market will accept our products and services and whether we are successful in identifying, completing and integrating acquisitions, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the Company’s most recent Annual Report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. While we do not intend to directly harvest, manufacture, distribute or sell cannabis or cannabis products, we may be detrimentally affected by a change in enforcement by federal or state governments and we may be subject to additional risks in connection with the evolving regulatory area and associated uncertainties. Any such effects may give rise to risks and uncertainties that are currently unknown or amplify others mentioned herein. Although the Company believes the expectations reflected in its forward-looking statements are reasonable and are based on reasonable assumptions, no assurance can be given that these assumptions are accurate or that any of these expectations will be achieved (in full or at all) or will prove to have been correct. Moreover, such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company, which may cause actual results to differ materially from those implied or expressed by the forward-looking statements. In addition, any forward-looking statements included in this press release represent the Company’s views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The Company assumes no obligation to correct or update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
Contact:
Jaime Hinojosa
Chief Financial Officer
Astrotech Corporation
(512) 485-9530
https://www.astrotechcorp.com/
FAQ
What is the total value of ASTC's new DHS contract for TRACER 1000?
How is ASTC's DHS contract for TRACER 1000 structured?
What is the purpose of ASTC's new DHS research contract?
When was ASTC awarded the DHS contract for TRACER 1000?
